首頁
Digbi Health

7月 2026Digbi Health的市場佔有率分析

Personalized care for obesity, diabetes, and gut health powered by your biology.

健康 > 健康 - 其他

域名digbihealth.com

成立年份2018

僱員51 - 200

年度營收$15M - $25M

Digbi Health

Digbi Health（包含公司地區）

digbihealth.com

查看更多網站流量與參與度資訊

Digbi Health截至 7月 2026 的總收入為 15M - 25M

Digbi Health 熱門網域產生的總收入

Digbi Health 熱門網域 3 年內的總收入

Digbi Health 熱門網域的總收入

digbihealth.com15M - 25M

透過銷售情報查看更多內容

Digbi Health的熱門網域總造訪量

了解Digbi Health市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

digbihealth.com8.7K

透過銷售情報查看更多內容

Digbi Health的熱門網域平均造訪時長

分析Digbi Health參與度指標。

過去 3 個月平均造訪時長

子公司細目

digbihealth.com00:01:08

透過銷售情報查看更多內容

Digbi Health的熱門網域平均頁面瀏覽量

了解Digbi Health如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

digbihealth.com1.99

透過銷售情報查看更多內容

Digbi Health按網域劃分的熱門競爭對手

7月 2026的熱門類似網站，依相似度排名

trymeasured.com公司名Measured僱員51 - 200總部美國, 加利福尼亞, Santa Monica年度營收$2M - $5M訪問總量11.2K食品和飲料 > 餐廳和送貨

使用的熱門技術Digbi Health

这些是Digbi Health顶级域名使用的行业网站技术

付費廣告 (18)

Google Adsense

付款與貨幣 (13)

Cart Functionality

轉換與分析 (10)

Google Analytics

市場行銷 (5)

Google Marketing Platform

更多技術

13

檢視所有

新聞與訊號來自Digbi Health

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Digbi Health launches GLP-Fit Program.Digbi Health unveils GLP-Fit™ Program: expands its Precision Biology platform to incorporate glp-1-based personalized care for obesity.

新聞Digbi Health hires Beverly Ibarrola as Vice President of Product and Community Marketing.Digbi Health, a leader in gut-microbiome and genetics-based telehealthcare, is pleased to announce that Beverly Ibarrola joined the Digbi team as its new Vice President of Product and Community Marketing.

新聞Digbi Health hired Daniel Almonacid on Jul 5th '21.MOUNTAIN VIEW, Calif. - July 5, 2021 - Digbi Health the first company with a clinically-proven genetics and gut-microbiome based digital care program to safely and sustainably treat and manage polychronic conditions - obesity, inflammatory gut, skin, mental and cardiometabolic health issues - is pleased to announce the appointments of Dr. Daniel Almonacid, as Chief Scientific Officer, and Dr. Parambir S. Dulai joins as Medical Director, Digestive and Mental Health, effective immediately.